The global sterility testing market size was valued at USD 35.78 billion in 2025 and is expected to reach USD 90.12 billion by 2033, at a CAGR of 12.24% during the forecast period
The market growth is largely fueled by the increasing production of pharmaceuticals, biologics, and cell & gene therapies, leading to higher demand for reliable sterility assurance across manufacturing processes
Furthermore, stringent regulatory requirements for product safety and quality, along with growing adoption of rapid microbiological testing technologies by pharmaceutical and biotechnology companies, are establishing sterility testing as a critical component of quality control. These converging factors are accelerating the adoption of sterility testing solutions, thereby significantly boosting the industry's growth